|
|
- 2017
Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal CancerDOI: 10.4143/crt.2016.121 Keywords: Esophageal neoplasms, Irinotecan, Cisplatin, Phase II clinical trial Abstract: The objective of this multicenter phase II study was to evaluate the efficacy and safety of irinotecan and cisplatin combination chemotherapy in metastatic, unresectable esophageal cancer
|
